
Twelve years of multiples investors have paid for Aster DM Healthcare Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Aster DM Healthcare Ltd trades at a P/E of 119.68× and P/B of 8.63×.
Twelve years of audited numbers for Aster DM Healthcare Ltd, switchable between annual and quarterly views, consolidated or standalone.
Aster DM Healthcare Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹40,905.66 Cr and reported EPS of ₹6.40.
| Period | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 6,721 | 7,963 | 8,739 | 8,608 | 10,253 | 11,933 | 3,699 | 4,138 | 4,643 |
| Other Income | 45 | 35 | 38 | 50 | 51 | 78 | 25 | 148 | 126 |
| Total Income | 6,767 | 7,997 | 8,776 | 8,658 | 10,304 | 12,011 | 3,724 | 4,287 | 4,769 |
| Cost of Goods Sold (COGS) | 2,059 | 2,420 | 2,635 | 2,549 | 2,892 | 3,532 | 916 | 938 | 1,049 |
| Gross Profit | 4,662 | 5,543 | 6,103 | 6,060 | 7,362 | 8,401 | 2,783 | 3,200 | 3,594 |
| +Operating Expenses | 4,049 | 4,680 | 4,845 | 4,997 | 5,878 | 6,836 | 2,205 | 2,436 | 2,693 |
| EBITDA | 613 | 863 | 1,258 | 1,063 | 1,483 | 1,565 | 578 | 765 | 901 |
| +Non-Operating Expenses | 612 | 484 | 926 | 911 | 898 | 1,110 | 330 | 323 | 355 |
| Profit Before Tax (PBT) | 305 | 411 | 330 | 202 | 636 | 534 | 273 | 490 | 607 |
| +Tax Expense | 26 | 43 | 15 | 27 | 36 | 60 | 57 | 134 | 143 |
| Profit After Tax (PAT) | 282 | 367 | 315 | 178 | 601 | 475 | 212 | 5,408 | 427 |
| Earnings Per Share (EPS) | 5.32 | 6.59 | 5.54 | 2.96 | 10.53 | 8.51 | 2.59 | 107.66 | 7.49 |
| Diluted Shares Outstanding (Nos.) | 51 | 51 | 50 | 50 | 50 | 50 | 50 | 50 | 52 |
| +Additional Disclosures | 8,675 | 10,102 | 11,244 | 10,990 | 12,728 | 15,260 | 4,491 | 9,765 | 5,181 |
| Sales Growth % | — | 18.47 | 9.74 | -1.49 | 19.11 | 16.38 | -69.00 | 11.88 | 12.20 |
| YoY Sales Growth % | — | 18.47 | 9.74 | -1.49 | 19.11 | 16.38 | -69.00 | 11.88 | 12.20 |
| Employee Cost % | 34 | 34 | 33 | 32 | 32 | 33 | 18 | 18 | 18 |
| Other Cost % | 26 | 25 | 22 | 26 | 25 | 24 | 41 | 40 | 40 |
| OPM % | 9 | 11 | 14 | 12 | 14 | 13 | 16 | 18 | 19 |
| Tax % | 9 | 10 | 5 | 14 | 6 | 11 | 21 | 27 | 24 |
| Profit Growth % | — | 30.40 | -14.33 | -43.49 | 237.99 | -20.89 | -55.51 | 2,456.20 | -92.10 |
| Gross Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA Margin % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Additional Fields | 315 | 557 | 672 | 445 | 843 | 785 | 358 | 516 | 637 |
Disclosed business segments at Aster DM Healthcare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Aster DM Healthcare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Why someone would buy Aster DM Healthcare Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.
Aster DM Healthcare Ltd's investment case rests on 10 positive markers and 9 flagged concerns drawn from the latest reported filings.
Robust quarterly sales (7.59%) and profit (9.08%) growth.
Significant DII stake increase (8.99% to 26.32%) shows growing confidence.
Impressive 5-year EPS growth of 81.35% indicates strong profitability trend.
Extensive geographical reach across multiple countries in healthcare.
Diversified business model across hospitals, clinics, and pharmacies.
High P/E ratio (109.66) suggests potential overvaluation compared to earnings.
Significant quarterly EPS decline (-98.38%) raises immediate profitability concerns.
Negative 5-year Free Cash Flow CAGR (-37.07%) indicates cash generation issues.
Relatively lower promoter holding (40.4%) compared to sector peers.
Substantial long-term negative revenue growth (3Y -26.10%) is concerning.
Trim if P/E re-rates above 156. The valuation cushion thins from there.
Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 46.42. Balance sheet risk re-prices growth multiples fast.
Exit if ROE slips below 8%. The operating engine is no longer compounding capital efficiently.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Aster DM Healthcare Ltd is highlighted for quick read-across.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Aster DM Healthcare Ltd — derived from the live tape, not yesterday's close.
Aster DM Healthcare Ltd last traded at ₹788.5 with an intraday range of ₹767.1–₹791.8 — live indicator, pivot and CPR signals below.
Standard pivot — most widely referenced.
| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 847.23 | +58.73 | +7.45% |
| R3 | 822.53 | +34.03 | +4.32% |
| R2 | 807.17 | +18.67 | +2.37% |
| R1 | 797.83 | +9.33 | +1.18% |
| PIVOT | 782.47 | -6.03 | -0.77% |
| CURRENT | 788.50 | — | — |
| S1 | 723.73 | -64.77 | -8.21% |
| S2 | 748.43 | -40.07 | -5.08% |
| S3 | 757.77 | -30.73 | -3.90% |
| S4 | 773.13 | -15.37 | -1.95% |
ASTERDM is trading Above CPR, indicating Bullishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: 767.1 ~ 778.5
Trading Above opening range, showing Bullishness
Auto-detected classical chart patterns for Aster DM Healthcare Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Daily traded volume and delivery percentage for Aster DM Healthcare Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Aster DM Healthcare Ltd stood at 39.8% of traded volume, against a 20-day average of 47.5%.
Filings Aster DM Healthcare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Aster DM Healthcare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 166 documents below.
Aster DM Healthcare Limited has informed the Exchange about Investor Presentation
Aster DM Healthcare Limited has informed the Exchange about Schedule of meet
Dr. Mandayapurath Azad Moopen has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Dr. Mandayapurath Azad Moopen has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Aster DM Healthcare Limited has informed the Exchange about Transcript
Promoter, director and designated-employee transactions in Aster DM Healthcare as reported to SEBI — buying and selling signals from the people who know the business best.
Aster DM Healthcare insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| Union (Mauritius) Holdings Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr | ₹433.00 |
| Union Investments Private Limited | Insider | 20 Mar 2025 | buy | +2.00 Cr | ₹865.16 Cr | ₹433.00 |
| Union Investments Private Limited | Insider | 07 Mar 2025 | buy | +8.51 Cr | ₹3,552.37 Cr | ₹417.45 |
| Union Investments Private Limited | Insider | 04 Mar 2025 | buy | +18.69 Cr | ₹7,362.04 Cr | ₹394.00 |
| Union (Mauritius) Holdings Limited | Insider | 04 Mar 2025 | buy | +2.00 Cr | ₹787.23 Cr | ₹394.00 |
Every dividend, stock split and bonus issue Aster DM Healthcare has declared, sequenced by announce and record date.
Aster DM Healthcare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
What Aster DM Healthcare Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Aster DM Healthcare Ltd operates in the Healthcare, listed as NSE: ASTERDM, BSE: 540975.

Aster DM Healthcare Limited is a prominent healthcare provider operating across a wide geographical expanse. Its services span several countries in the Middle East and South Asia, including India, the United Arab Emirates, Qatar, Oman, Saudi Arabia, Jordan, Kuwait, Bahrain, and Mauritius. This extensive reach establishes Aster DM as a significant player in the international healthcare market, delivering services to a diverse patient population.
The company's business is structured around four key segments: Hospitals, Clinics, Retail Pharmacies, and Others. The Hospitals segment encompasses the operation of large-scale hospitals, often including integrated in-house pharmacies to provide comprehensive patient care within a single facility. Similarly, the Clinics segment focuses on smaller-scale clinics, also frequently with integrated pharmacies for convenient access to medications.
Aster DM's Retail Pharmacies segment represents a substantial portion of its business. This encompasses a network of both physical retail pharmacies and online pharmacy services, extending access to medications and healthcare products beyond the company's hospital and clinic settings. The addition of optical outlets further diversifies this segment, offering comprehensive eye care and related products to a wider customer base.
The "Others" segment encompasses a variety of supporting services and business activities. This includes healthcare consultancy, offering specialized advice and expertise to other healthcare organizations or institutions, as well as other ancillary services that support the core operations of the company’s hospital, clinic, and retail pharmacy networks. This diversified approach allows Aster DM to expand its revenue streams and offers opportunities for growth and strategic partnerships.
In summary, Aster DM Healthcare Limited's business model centers around providing a comprehensive range of healthcare services, from hospital-based care to retail pharmacy access, across multiple countries. Its diversified business structure, coupled with its international reach, positions the company for continued growth and influence in the global healthcare landscape. The company's long history, beginning in 1987, demonstrates its enduring commitment to delivering quality healthcare services and its ability to adapt and expand within a dynamic market.
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
The current share price of Aster DM Healthcare Ltd (ASTERDM) is ₹788.5. Today, the stock has gained by ₹22.55 (2.94%), trading in a range of ₹767.1 to ₹791.8. The stock opened at ₹768 with a trading volume of 3,55,032 shares.
Aster DM Healthcare Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹40,905.66 crores, P/E ratio of 119.68, ROE of 10.07%, and ROCE of 10.70%. The dividend yield stands at 0.51%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Aster DM Healthcare Ltd (ASTERDM) is ₹836.5, while the 52-week low is ₹519.1. Currently trading at ₹788.5, the stock is 84.9% away from its 52-week low and 5.7% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Aster DM Healthcare Ltd stock at ₹788.5 depends on multiple factors. The stock is currently trading with a P/E ratio of 119.68 and P/B ratio of 8.63. Today's performance shows a gain of 2.94%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Aster DM Healthcare Ltd offers a dividend yield of 0.51%, which means for every ₹100 invested at the current price of ₹788.5, you can expect to receive approximately ₹0.51 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Aster DM Healthcare Ltd's key financial metrics include: P/E Ratio: 119.68, P/B Ratio: 8.63, ROE: 10.07%, ROCE: 10.70%, Dividend Yield: 0.51%, EPS: ₹6.40, Book Value: ₹88.8, and Debt-to-Equity: 45.92. The company's market cap stands at ₹40,905.66 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Aster DM Healthcare Ltd stock opened at ₹768 and is currently trading at ₹788.5, showing a gain of ₹22.55 (2.94%). The intraday high is ₹791.8 and low is ₹767.1. The trading volume stands at 3,55,032 shares, indicating moderate market participation today.
Aster DM Healthcare Ltd has a Price-to-Earnings (P/E) ratio of 119.68, which means investors are willing to pay ₹119.68 for every ₹1 of earnings. With an EPS of ₹6.40, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Aster DM Healthcare Ltd (ASTERDM) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.
Peers, sector trends, screeners and strategy playbooks contextual to this stock.